Lianyungang Guike Pharmaceutical

Lianyungang Guike Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in China, primarily focused on the production of anti-malarial active pharmaceutical ingredients (APIs) and finished dosage forms. Operating as a subsidiary of Guilin Pharmaceutical under the Fosun Pharma group, the company is a critical player in the global supply chain for artemisinin-based combination therapies (ACTs). Its production lines for artemether and lumefantrine have received WHO Prequalification (WHO-PQ), enabling the company to serve international procurement agencies and global health initiatives. In addition to its core antimalarial portfolio, Lianyungang Guike manufactures a range of generic small molecule drugs and provides contract manufacturing services. The company maintains high-standard GMP facilities to ensure compliance with both domestic and international regulatory requirements.